• Fri, June 6, 2025
  • Sat, June 7, 2025
  • Sun, June 8, 2025
  • Mon, June 9, 2025
  • Tue, June 10, 2025
  • Wed, June 11, 2025
  • Thu, June 12, 2025
  • Fri, June 13, 2025

A kidney disease showdown, and eye risk linked to GLP-1s

And more biotech news brought to you by The Readout.
The article from STAT News dated June 6, 2025, discusses several key developments in the biotech industry. Otsuka and Vera Therapeutics have entered into a $1.8 billion deal to develop and commercialize treatments for kidney diseases, highlighting the growing focus on renal care. Additionally, the article covers the ongoing debate around GLP-1 drugs, with new data suggesting their potential in managing obesity and related conditions. The FDA's recent approval of the Elsa device for early detection of Alzheimer's disease marks a significant advancement in neurodegenerative diagnostics. Lastly, changes in Medicare Advantage plans are noted, which could impact coverage and costs for beneficiaries, reflecting broader shifts in healthcare policy and insurance.

Read the Full STAT Article at:
https://www.statnews.com/2025/06/06/biotech-news-otsuka-vera-therapeutics-glp-1-elsa-fda-medicare-advantage-the-readout/